Rockwell Automation's Trading Volume Drops 43% Ranking 445th Amid Digital Transformation Success

On June 27, 2025, Rockwell Automation Inc. (ROK) saw a trading volume of $203 million, a 43.32% decrease from the previous day, ranking 445th in the day's stock market. The stock price rose by 1.11%, marking the second consecutive day of gains, with a total increase of 2.28% over the past two days.

Rockwell Automation, Inc. has recently announced a significant development in its digital transformation initiatives. The company's FactoryTalk® PharmaSuite® manufacturing execution system (MES) has been adopted by Sintetica SA, a leading pharmaceutical supplier based in Switzerland. This adoption is part of Sintetica's extensive digitalization program aimed at enhancing quality, monitoring, and operational efficiency.

Sintetica, established in 1921, produces a range of innovative therapies, including drugs for anesthesia, pain management, intensive care, and neuromodulation. The implementation of the PharmaSuite MES at Sintetica's production facility in Switzerland is expected to improve quality control, monitoring, and insights, while also accelerating batch reviews to shorten the time to market.

Roger Gaemperle, EMEA head of industry strategy and marketing for life sciences at Rockwell Automation, highlighted the operational pressures faced by pharmaceutical companies from consumers, industry, and legislative bodies. He emphasized that creating a digital foundation at the outset of production operations provides faster and easier access to essential insights throughout the value chain, driving value for pharmaceutical customers.

Rockwell Automation consultants collaborated closely with Sintetica during the design and implementation phases, ensuring the software's agility to meet Sintetica's evolving needs. The pilot deployment on two lines has received positive feedback from operators, who have found the data-driven insights and actions empowering, reducing the time spent on monitoring, recording, and disseminating essential batch information and operational machine logs.

Pierluigi De Rosa, digital affairs – application manager at Sintetica, described the digital transformation as a comprehensive journey of self-improvement. The initiative aims to enhance efficiency across production operations and strengthen quality assurance and legislation programs. Although not yet implemented across all product lines, the PharmaSuite MES is being used at the preparation stage for the majority of Sintetica's projects, providing a stronger and more accurate starting point.